{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Placebo+Tablet&page=2", "query": { "intervention": "Matching Placebo Tablet", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Placebo+Tablet&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-17T16:32:00.069Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00329459", "title": "Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine Disorders" ], "interventions": [ { "name": "sumatriptan succinate/naproxen sodium", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 320, "start_date": "2006-05", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2016-10-24", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 34, "location_summary": "Mesa, Arizona • Little Rock, Arkansas • Fair Oaks, California + 31 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fair Oaks", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00329459" }, { "nct_id": "NCT05717062", "title": "Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Snakebite", "Envenoming, Snake" ], "interventions": [ { "name": "Varespladib intravenous form", "type": "DRUG" }, { "name": "varespladib-methyl- oral form", "type": "DRUG" }, { "name": "Placebo intravenous form", "type": "DRUG" }, { "name": "Placebo - oral form", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ophirex, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2023-05-30", "completion_date": "2025-02-24", "has_results": false, "last_update_posted_date": "2025-06-27", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Palm Springs, California + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Palm Springs", "state": "California" }, { "city": "Rosamond", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05717062" }, { "nct_id": "NCT03576066", "title": "A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Hepatitis B" ], "interventions": [ { "name": "ABI-H0731", "type": "DRUG" }, { "name": "SOC NUC", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Assembly Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 73, "start_date": "2018-06-11", "completion_date": "2019-07-05", "has_results": true, "last_update_posted_date": "2021-02-17", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 17, "location_summary": "Beverly Hills, California • Coronado, California • Los Angeles, California + 10 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Coronado", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03576066" }, { "nct_id": "NCT01789970", "title": "Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Hydrocodone ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 625, "start_date": "2013-03", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2017-06-05", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 87, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 71 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01789970" }, { "nct_id": "NCT06671483", "title": "A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Zasocitinib", "type": "DRUG" }, { "name": "Active Comparator", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1088, "start_date": "2025-03-03", "completion_date": "2028-01-28", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 51, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Fountain Valley, California + 45 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06671483" }, { "nct_id": "NCT07013591", "title": "Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Artery Bypass Graft" ], "interventions": [ { "name": "MIB-626", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2026-06-10", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07013591" }, { "nct_id": "NCT01715818", "title": "A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease, Diabetes Mellitus Type 2" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "aleglitazar", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1999, "start_date": "2012-12", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 143, "location_summary": "Muscle Shoals, Alabama • Gilbert, Arizona • Phoenix, Arizona + 126 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Cudahy", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01715818" }, { "nct_id": "NCT06383273", "title": "A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "MELT-300 sublingual tablet", "type": "DRUG" }, { "name": "Midalozam sublingual tablet", "type": "DRUG" }, { "name": "Placebo sublingual tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melt Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 528, "start_date": "2024-05-01", "completion_date": "2025-01", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 12, "location_summary": "Chico, California • Grand Junction, Colorado • Jacksonville, Florida + 9 more", "locations": [ { "city": "Chico", "state": "California" }, { "city": "Grand Junction", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Alexandria", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06383273" }, { "nct_id": "NCT07283770", "title": "Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-581", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "D-IVA", "type": "DRUG" }, { "name": "TEZ", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 136, "start_date": "2025-12-09", "completion_date": "2026-11-19", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07283770" }, { "nct_id": "NCT00293059", "title": "Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metrorrhagia" ], "interventions": [ { "name": "Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 190, "start_date": "2005-12", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2013-11-27", "last_synced_at": "2026-09-17T16:32:00.069Z", "location_count": 37, "location_summary": "Lake Havasu City, Arizona • Greenbrae, California • Los Angeles, California + 32 more", "locations": [ { "city": "Lake Havasu City", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pacific Palisades", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00293059" } ] }